===== phenotype 5=================================================================
proportion of pts: 0.116620388735
lambda: 13818.3201133
----------------------------------------
Ischemic heart disease	0.157
Other forms of heart disease	0.139
Disorders of lipoid metabolism	0.125
Hypertensive disease	0.119
Range name na	0.101
Nephritis, nephrotic syndrome, and nephrosis	0.097
Symptoms involving respiratory system and other chest symptoms	0.096
Anemias	0.093
Disorders of fluid, electrolyte, and acid-base balance	0.075
----------------------------------------
Anti-Arrhythmia Agents	0.084
Adrenergic beta-1 Receptor Antagonists	0.083
Sympatholytics	0.080
Diuretics	0.079
Platelet Aggregation Inhibitors	0.078
Antipyretics	0.078
Fibrinolytic Agents	0.076
Cyclooxygenase Inhibitors	0.076
Anti-Inflammatory Agents, Non-Steroidal	0.076
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.074
Anticholesteremic Agents	0.073
Antihypertensive Agents	0.072
Vasodilator Agents	0.072
===== phenotype 13=================================================================
proportion of pts: 0.138040460135
lambda: 11356.026408
----------------------------------------
Diabetes	0.247
Disorders of lipoid metabolism	0.181
Hypertensive disease	0.180
Ischemic heart disease	0.117
Disorders of the eye and adnexa	0.102
Range name na	0.088
General symptoms	0.084
----------------------------------------
Hypoglycemic Agents	0.117
Anti-Arrhythmia Agents	0.091
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.088
Anticholesteremic Agents	0.086
Adrenergic beta-1 Receptor Antagonists	0.080
Cyclooxygenase Inhibitors	0.079
Anti-Inflammatory Agents, Non-Steroidal	0.079
Platelet Aggregation Inhibitors	0.078
Fibrinolytic Agents	0.077
Angiotensin-Converting Enzyme Inhibitors	0.077
Antihypertensive Agents	0.075
Sympatholytics	0.074
===== phenotype 0=================================================================
proportion of pts: 0.120190400635
lambda: 10317.6198918
----------------------------------------
Other diseases of urinary system	0.134
Disorders of lipoid metabolism	0.128
Hypertensive disease	0.126
Symptoms involving urinary system	0.112
General symptoms	0.099
Arthropathies and related disorders	0.090
Dorsopathies	0.081
Diseases of male genital organs	0.080
Range name na	0.077
Symptoms involving respiratory system and other chest symptoms	0.074
----------------------------------------
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.101
Anticholesteremic Agents	0.100
Platelet Aggregation Inhibitors	0.097
Fibrinolytic Agents	0.096
Hypolipidemic Agents	0.095
Antipyretics	0.090
Cyclooxygenase Inhibitors	0.087
Anti-Inflammatory Agents, Non-Steroidal	0.086
Antihypertensive Agents	0.085
Vasodilator Agents	0.083
Angiotensin-Converting Enzyme Inhibitors	0.080
===== phenotype 27=================================================================
proportion of pts: 0.11463704879
lambda: 10170.7536676
----------------------------------------
Hypertensive disease	0.135
General symptoms	0.122
Symptoms involving respiratory system and other chest symptoms	0.114
Range name na	0.113
Disorders of lipoid metabolism	0.103
Symptoms involving head and neck	0.091
Nutritional deficiencies	0.085
Disorders of the eye and adnexa	0.082
Other diseases of intestines and peritoneum	0.079
Symptoms involving urinary system	0.076
----------------------------------------
Angiotensin-Converting Enzyme Inhibitors	0.090
Vitamins	0.090
Calcium Channel Blockers	0.086
Vasodilator Agents	0.086
Fibrinolytic Agents	0.084
Platelet Aggregation Inhibitors	0.083
Antipyretics	0.082
Antihypertensive Agents	0.081
Cardiotonic Agents	0.081
Bone Density Conservation Agents	0.080
Cyclooxygenase Inhibitors	0.079
Anti-Inflammatory Agents, Non-Steroidal	0.078
===== phenotype 9=================================================================
proportion of pts: 0.115430384768
lambda: 10101.8850735
----------------------------------------
Diabetes	0.186
Disorders of lipoid metabolism	0.127
Hypertensive disease	0.126
Disorders of the eye and adnexa	0.111
Rheumatism, excluding the back	0.109
Organic sleep disorders	0.088
Range name na	0.085
Diseases of the ear and mastoid process	0.084
Symptoms involving skin and other integumentary tissue	0.083
----------------------------------------
Hypoglycemic Agents	0.109
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.099
Antipyretics	0.094
Anticholesteremic Agents	0.094
Hypolipidemic Agents	0.092
Anti-Inflammatory Agents, Non-Steroidal	0.091
Cyclooxygenase Inhibitors	0.090
Platelet Aggregation Inhibitors	0.089
Fibrinolytic Agents	0.087
Antihypertensive Agents	0.081
Anti-Inflammatory Agents	0.072
===== phenotype 20=================================================================
proportion of pts: 0.11106703689
lambda: 9740.17006232
----------------------------------------
Other diseases of skin and subcutaneous tissue	0.157
Hypertensive disease	0.094
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.091
Malignant neoplasm of skin	0.087
Arthropathies and related disorders	0.086
Rheumatism, excluding the back	0.085
Neoplasm of uncertain behavior of other sites & tissues	0.084
Symptoms involving skin and other integumentary tissue	0.083
Dorsopathies	0.081
Other forms of heart disease	0.077
Infections of skin and subcutaneous tissue	0.074
----------------------------------------
Antipyretics	0.104
Platelet Aggregation Inhibitors	0.102
Fibrinolytic Agents	0.100
Cyclooxygenase Inhibitors	0.097
Antihypertensive Agents	0.097
Anti-Inflammatory Agents, Non-Steroidal	0.096
Vitamins	0.087
Anti-Arrhythmia Agents	0.084
Bone Density Conservation Agents	0.079
Vasodilator Agents	0.078
Diuretics	0.076
===== phenotype 46=================================================================
proportion of pts: 0.123760412535
lambda: 9560.99712745
----------------------------------------
Disorders of thyroid gland	0.174
Hypertensive disease	0.150
Disorders of lipoid metabolism	0.143
Organic sleep disorders	0.120
Dorsopathies	0.087
Symptoms involving respiratory system and other chest symptoms	0.086
Other symptoms involving abdomen and pelvis	0.085
General symptoms	0.080
Diseases of esophagus, stomach, and duodenum	0.075
----------------------------------------
Diuretics	0.095
Anti-Arrhythmia Agents	0.094
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.091
Anticholesteremic Agents	0.088
Antihypertensive Agents	0.087
Anti-Allergic Agents	0.080
Anti-Inflammatory Agents, Non-Steroidal	0.080
Sodium Chloride Symporter Inhibitors	0.080
Cyclooxygenase Inhibitors	0.079
Calcium Channel Blockers	0.079
Antipyretics	0.076
Platelet Aggregation Inhibitors	0.073
===== phenotype 47=================================================================
proportion of pts: 0.127727092424
lambda: 9296.79470308
----------------------------------------
Disorders of lipoid metabolism	0.154
Hypertensive disease	0.147
Acute respiratory infections	0.130
Arthropathies and related disorders	0.128
Diabetes	0.097
Rheumatism, excluding the back	0.090
Other diseases of the upper respiratory tract	0.085
Symptoms involving respiratory system and other chest symptoms	0.085
Range name na	0.083
----------------------------------------
Cyclooxygenase Inhibitors	0.120
Anti-Inflammatory Agents, Non-Steroidal	0.119
Antipyretics	0.117
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.116
Fibrinolytic Agents	0.113
Platelet Aggregation Inhibitors	0.113
Anticholesteremic Agents	0.111
Antihypertensive Agents	0.102
Diuretics	0.089
===== phenotype 34=================================================================
proportion of pts: 0.111463704879
lambda: 8965.02823872
----------------------------------------
Hypertensive disease	0.126
Range name na	0.122
Rheumatism, excluding the back	0.107
Diabetes	0.105
Disorders of lipoid metabolism	0.099
Other forms of heart disease	0.097
Arthropathies and related disorders	0.092
Disorders of the eye and adnexa	0.090
General symptoms	0.087
Diseases of veins and lymphatics, and other diseases of circulatory system	0.075
----------------------------------------
Diuretics	0.141
Calcium Channel Blockers	0.126
Sodium Potassium Chloride Symporter Inhibitors	0.126
Vasodilator Agents	0.123
Anti-Arrhythmia Agents	0.120
Sympatholytics	0.105
Anticoagulants	0.092
Rodenticides	0.086
Antihypertensive Agents	0.082
===== phenotype 21=================================================================
proportion of pts: 0.103530345101
lambda: 8757.62309733
----------------------------------------
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.119
Arthropathies and related disorders	0.115
Rheumatism, excluding the back	0.104
Hypertensive disease	0.103
Range name na	0.094
Dorsopathies	0.083
Other diseases of urinary system	0.081
Symptoms involving urinary system	0.080
General symptoms	0.078
Diseases of esophagus, stomach, and duodenum	0.072
Disorders of the peripheral nervous system	0.071
----------------------------------------
Calcium Channel Blockers	0.128
Anti-Arrhythmia Agents	0.114
Anti-Ulcer Agents	0.114
Anticonvulsants	0.107
Anti-Anxiety Agents	0.105
Analgesics	0.103
Antipyretics	0.089
Serotonin Uptake Inhibitors	0.088
Cyclooxygenase Inhibitors	0.077
Anti-Inflammatory Agents, Non-Steroidal	0.075
===== phenotype 22=================================================================
proportion of pts: 0.115827052757
lambda: 8619.81740246
----------------------------------------
Other diseases of the upper respiratory tract	0.172
Hypertensive disease	0.154
Acute respiratory infections	0.143
Symptoms involving respiratory system and other chest symptoms	0.137
Chronic obstructive pulmonary disease and allied conditions	0.113
Disorders of lipoid metabolism	0.107
Disorders of the eye and adnexa	0.097
Diseases of esophagus, stomach, and duodenum	0.077
----------------------------------------
Anti-Inflammatory Agents	0.120
Anti-Allergic Agents	0.117
Bronchodilator Agents	0.116
Dermatologic Agents	0.102
Histamine H1 Antagonists, Non-Sedating	0.099
Glucocorticoids	0.095
Anti-Bacterial Agents	0.092
Antihypertensive Agents	0.091
Anti-Ulcer Agents	0.088
Proton Pump Inhibitors	0.081
===== phenotype 42=================================================================
proportion of pts: 0.105910353035
lambda: 8566.13784106
----------------------------------------
Hypertensive disease	0.145
General symptoms	0.117
Range name na	0.105
Disorders of lipoid metabolism	0.101
Symptoms involving respiratory system and other chest symptoms	0.100
Arthropathies and related disorders	0.095
Rheumatism, excluding the back	0.090
Symptoms involving head and neck	0.087
Dorsopathies	0.082
Disorders of the eye and adnexa	0.078
----------------------------------------
Hypnotics and Sedatives	0.135
Anticonvulsants	0.135
Anti-Anxiety Agents	0.129
Antiemetics	0.128
GABA Modulators	0.123
Histamine H1 Antagonists	0.094
Analgesics	0.090
Serotonin Uptake Inhibitors	0.086
Antidepressive Agents, Second-Generation	0.081
===== phenotype 2=================================================================
proportion of pts: 0.113843712812
lambda: 8354.70109205
----------------------------------------
Hypertensive disease	0.157
Disorders of lipoid metabolism	0.142
Other forms of heart disease	0.136
Symptoms involving respiratory system and other chest symptoms	0.102
Symptoms involving skin and other integumentary tissue	0.100
Symptoms involving cardiovascular system	0.097
Range name na	0.096
Nonspecific findings on examination of blood	0.086
Ischemic heart disease	0.084
----------------------------------------
Vasodilator Agents	0.107
Anti-Inflammatory Agents, Non-Steroidal	0.103
Cyclooxygenase Inhibitors	0.103
Antihypertensive Agents	0.102
Anti-Arrhythmia Agents	0.101
Antipyretics	0.101
Diuretics	0.098
Fibrinolytic Agents	0.097
Platelet Aggregation Inhibitors	0.096
Calcium Channel Blockers	0.093
===== phenotype 48=================================================================
proportion of pts: 0.105513685046
lambda: 8262.34360185
----------------------------------------
Diseases of esophagus, stomach, and duodenum	0.172
Hypertensive disease	0.129
Arthropathies and related disorders	0.121
Disorders of lipoid metabolism	0.110
Rheumatism, excluding the back	0.106
Symptoms involving respiratory system and other chest symptoms	0.106
General symptoms	0.097
Disorders of thyroid gland	0.086
Symptoms involving digestive system	0.074
----------------------------------------
Proton Pump Inhibitors	0.114
Anti-Ulcer Agents	0.111
Vitamins	0.098
Cyclooxygenase Inhibitors	0.091
Anti-Inflammatory Agents, Non-Steroidal	0.089
Fibrinolytic Agents	0.087
Platelet Aggregation Inhibitors	0.087
Bone Density Conservation Agents	0.084
Antipyretics	0.084
Antihypertensive Agents	0.078
Vasodilator Agents	0.077
===== phenotype 12=================================================================
proportion of pts: 0.0987703292344
lambda: 7760.02966973
----------------------------------------
Other forms of heart disease	0.143
Range name na	0.136
Hypertensive disease	0.127
Disorders of lipoid metabolism	0.124
Ischemic heart disease	0.113
Symptoms involving respiratory system and other chest symptoms	0.100
Arthropathies and related disorders	0.095
Rheumatism, excluding the back	0.082
Dorsopathies	0.081
----------------------------------------
Hypolipidemic Agents	0.102
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.100
Anticoagulants	0.100
Anti-Arrhythmia Agents	0.099
Anticholesteremic Agents	0.094
Sympatholytics	0.093
Rodenticides	0.092
Anti-Allergic Agents	0.086
Histamine H1 Antagonists, Non-Sedating	0.082
Platelet Aggregation Inhibitors	0.077
Fibrinolytic Agents	0.076
===== phenotype 28=================================================================
proportion of pts: 0.0920269734232
lambda: 7590.77220222
----------------------------------------
Disorders of lipoid metabolism	0.139
Ischemic heart disease	0.126
Hypertensive disease	0.119
Symptoms involving respiratory system and other chest symptoms	0.113
Other diseases of skin and subcutaneous tissue	0.093
Chronic obstructive pulmonary disease and allied conditions	0.091
Range name na	0.083
General symptoms	0.082
Cerebrovascular disease	0.079
Arthropathies and related disorders	0.077
----------------------------------------
Hypolipidemic Agents	0.119
Anticholesteremic Agents	0.116
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.108
Vasodilator Agents	0.103
Platelet Aggregation Inhibitors	0.101
Fibrinolytic Agents	0.098
Cyclooxygenase Inhibitors	0.094
Anti-Inflammatory Agents, Non-Steroidal	0.089
Antipyretics	0.089
Explosive Agents	0.083
===== phenotype 39=================================================================
proportion of pts: 0.119793732646
lambda: 7454.76466836
----------------------------------------
Nutritional deficiencies	0.159
Hypertensive disease	0.153
Range name na	0.128
Disorders of lipoid metabolism	0.113
Disorders of the eye and adnexa	0.103
Arthropathies and related disorders	0.101
Anemias	0.088
General symptoms	0.081
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.074
----------------------------------------
Vitamins	0.146
Bone Density Conservation Agents	0.136
Vitamin B Complex	0.129
Antioxidants	0.125
Antihypertensive Agents	0.105
Antipyretics	0.093
Anti-Inflammatory Agents, Non-Steroidal	0.090
Serotonin Uptake Inhibitors	0.089
Cyclooxygenase Inhibitors	0.087
===== phenotype 17=================================================================
proportion of pts: 0.0904403014677
lambda: 7386.30999248
----------------------------------------
Hypertensive disease	0.144
Gout	0.136
Disorders of lipoid metabolism	0.127
Range name na	0.124
Ischemic heart disease	0.115
Other forms of heart disease	0.099
Dorsopathies	0.086
Arthropathies and related disorders	0.085
Diabetes	0.085
----------------------------------------
Gout Suppressants	0.109
Enzyme Inhibitors	0.091
Antimetabolites	0.090
Antipyretics	0.084
Adrenergic alpha-1 Receptor Antagonists	0.084
Vasodilator Agents	0.083
Anti-Inflammatory Agents, Non-Steroidal	0.081
Cyclooxygenase Inhibitors	0.079
Free Radical Scavengers	0.079
Antihypertensive Agents	0.074
Fibrinolytic Agents	0.074
Platelet Aggregation Inhibitors	0.072
===== phenotype 25=================================================================
proportion of pts: 0.115033716779
lambda: 7082.86623024
----------------------------------------
Dorsopathies	0.167
Arthropathies and related disorders	0.153
Hypertensive disease	0.139
Rheumatism, excluding the back	0.137
Range name na	0.119
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.100
Disorders of lipoid metabolism	0.100
General symptoms	0.086
----------------------------------------
Anti-Inflammatory Agents	0.137
Calcium Channel Blockers	0.126
Glucocorticoids	0.126
Anti-Allergic Agents	0.124
Dermatologic Agents	0.108
Antihypertensive Agents	0.105
Bronchodilator Agents	0.099
Anti-Inflammatory Agents, Non-Steroidal	0.089
Cyclooxygenase Inhibitors	0.085
===== phenotype 11=================================================================
proportion of pts: 0.111860372868
lambda: 6679.2444502
----------------------------------------
Hypertensive disease	0.151
Range name na	0.151
Rheumatism, excluding the back	0.116
Arthropathies and related disorders	0.114
General symptoms	0.107
Disorders of lipoid metabolism	0.102
Symptoms involving respiratory system and other chest symptoms	0.092
Dorsopathies	0.089
Other forms of heart disease	0.077
----------------------------------------
Analgesics, Opioid	0.152
Narcotics	0.143
Immunosuppressive Agents	0.111
Antimalarials	0.109
Anti-Infective Agents, Urinary	0.107
Enzyme Inhibitors	0.104
Antirheumatic Agents	0.095
Antifungal Agents	0.094
Anti-Infective Agents, Local	0.087
===== phenotype 44=================================================================
proportion of pts: 0.10392701309
lambda: 6438.04258222
----------------------------------------
Hypertensive disease	0.126
Disorders of lipoid metabolism	0.115
Other diseases of skin and subcutaneous tissue	0.107
Disorders of the eye and adnexa	0.105
Arthropathies and related disorders	0.103
Mycoses	0.096
Range name na	0.093
Ischemic heart disease	0.090
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.083
Diabetes	0.082
----------------------------------------
Angiotensin-Converting Enzyme Inhibitors	0.138
Cardiotonic Agents	0.135
Anticholesteremic Agents	0.127
Anti-Ulcer Agents	0.124
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.121
Antihypertensive Agents	0.121
Proton Pump Inhibitors	0.118
Diuretics	0.116
===== phenotype 24=================================================================
proportion of pts: 0.0840936136454
lambda: 6383.46427199
----------------------------------------
Hypertensive disease	0.166
Range name na	0.137
Disorders of lipoid metabolism	0.119
Arthropathies and related disorders	0.118
Symptoms involving respiratory system and other chest symptoms	0.110
Rheumatism, excluding the back	0.090
General symptoms	0.089
Ischemic heart disease	0.087
Diabetes	0.084
----------------------------------------
Adrenergic beta-1 Receptor Antagonists	0.122
Enzyme Inhibitors	0.107
Sympatholytics	0.106
Immunosuppressive Agents	0.104
Folic Acid Antagonists	0.100
Dermatologic Agents	0.095
Nucleic Acid Synthesis Inhibitors	0.094
Antimetabolites, Antineoplastic	0.092
Antirheumatic Agents	0.090
Abortifacient Agents, Nonsteroidal	0.090
===== phenotype 31=================================================================
proportion of pts: 0.10035700119
lambda: 6092.01055504
----------------------------------------
Diseases of arteries, arterioles, and capillaries	0.125
Symptoms involving cardiovascular system	0.105
Diseases of male genital organs	0.097
Other diseases of urinary system	0.096
Other symptoms involving abdomen and pelvis	0.091
Other forms of heart disease	0.089
Malignant neoplasm of male and female genital organs	0.085
Other diseases of intestines and peritoneum	0.084
Hypertensive disease	0.082
Diseases of veins and lymphatics, and other diseases of circulatory system	0.074
Other and unspecified effects of external causes	0.070
----------------------------------------
Anticholesteremic Agents	0.109
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.106
Antihypertensive Agents	0.105
Antipyretics	0.103
Platelet Aggregation Inhibitors	0.100
Cyclooxygenase Inhibitors	0.099
Fibrinolytic Agents	0.097
Anti-Inflammatory Agents, Non-Steroidal	0.095
Vasodilator Agents	0.093
Anti-Arrhythmia Agents	0.093
===== phenotype 45=================================================================
proportion of pts: 0.0936136453788
lambda: 5905.58037738
----------------------------------------
Other diseases of skin and subcutaneous tissue	0.146
Hypertensive disease	0.136
Disorders of lipoid metabolism	0.126
Neoplasm of uncertain behavior of other sites & tissues	0.111
General symptoms	0.105
Diseases of esophagus, stomach, and duodenum	0.103
Range name na	0.096
Other inflammatory conditions of skin and subcutaneous tissue	0.090
Symptoms involving respiratory system and other chest symptoms	0.088
----------------------------------------
Anti-Ulcer Agents	0.119
Proton Pump Inhibitors	0.117
Anti-Allergic Agents	0.113
Anti-Inflammatory Agents	0.102
Antihypertensive Agents	0.097
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.095
Anticholesteremic Agents	0.095
Bronchodilator Agents	0.092
Histamine H1 Antagonists, Non-Sedating	0.092
Anti-Inflammatory Agents, Non-Steroidal	0.078
===== phenotype 32=================================================================
proportion of pts: 0.0916303054344
lambda: 5820.02782057
----------------------------------------
Rheumatism, excluding the back	0.131
Hypertensive disease	0.119
Arthropathies and related disorders	0.113
Sprains and strains of joints and adjacent muscles	0.105
Dorsopathies	0.103
Symptoms involving respiratory system and other chest symptoms	0.089
Disorders of lipoid metabolism	0.089
Diseases of oral cavity, salivary glands, and jaws	0.088
Range name na	0.086
Other diseases of skin and subcutaneous tissue	0.075
----------------------------------------
Anti-Arrhythmia Agents	0.124
Anesthetics, Local	0.099
Antihypertensive Agents	0.094
Vasodilator Agents	0.092
Anti-Inflammatory Agents	0.092
Anti-Inflammatory Agents, Non-Steroidal	0.088
Cyclooxygenase Inhibitors	0.087
Antipyretics	0.087
Fibrinolytic Agents	0.079
Anti-Allergic Agents	0.079
Platelet Aggregation Inhibitors	0.079
===== phenotype 19=================================================================
proportion of pts: 0.0753669178897
lambda: 5484.75256385
----------------------------------------
Hypertensive disease	0.177
Disorders of lipoid metabolism	0.128
Arthropathies and related disorders	0.108
Range name na	0.104
Diabetes	0.103
Disorders of thyroid gland	0.103
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.096
Nutritional deficiencies	0.091
Rheumatism, excluding the back	0.089
----------------------------------------
Dermatologic Agents	0.121
Anti-Allergic Agents	0.103
Bronchodilator Agents	0.098
Anti-Inflammatory Agents	0.098
Enzyme Inhibitors	0.096
Immunosuppressive Agents	0.092
Antirheumatic Agents	0.084
Folic Acid Antagonists	0.078
Abortifacient Agents, Nonsteroidal	0.078
Nucleic Acid Synthesis Inhibitors	0.077
Antimetabolites, Antineoplastic	0.076
===== phenotype 16=================================================================
proportion of pts: 0.0916303054344
lambda: 4987.87492682
----------------------------------------
Chronic obstructive pulmonary disease and allied conditions	0.155
Symptoms involving respiratory system and other chest symptoms	0.131
Diabetes	0.126
Hypertensive disease	0.117
Disorders of lipoid metabolism	0.113
Ischemic heart disease	0.098
Other diseases of respiratory system	0.098
Range name na	0.088
Pneumonia and influenza	0.073
----------------------------------------
Tocolytic Agents	0.183
Bronchodilator Agents	0.168
Adrenergic beta-2 Receptor Agonists	0.156
Vasodilator Agents	0.137
Antipyretics	0.130
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.115
Antihypertensive Agents	0.111
===== phenotype 8=================================================================
proportion of pts: 0.0936136453788
lambda: 4985.77500611
----------------------------------------
Hypertensive disease	0.127
Symptoms involving respiratory system and other chest symptoms	0.117
Disorders of lipoid metabolism	0.115
Range name na	0.109
Diseases of esophagus, stomach, and duodenum	0.105
Diabetes	0.097
Ischemic heart disease	0.091
General symptoms	0.086
Other symptoms involving abdomen and pelvis	0.078
Dorsopathies	0.074
----------------------------------------
Proton Pump Inhibitors	0.223
Anti-Ulcer Agents	0.216
Hypnotics and Sedatives	0.174
Anti-Anxiety Agents	0.152
GABA Modulators	0.133
Antipyretics	0.102
===== phenotype 7=================================================================
proportion of pts: 0.0872669575565
lambda: 4944.23224636
----------------------------------------
Range name na	0.156
Hypertensive disease	0.150
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.117
Disorders of lipoid metabolism	0.115
Disorders of thyroid gland	0.103
Malignant neoplasm of breast	0.098
Rheumatism, excluding the back	0.090
General symptoms	0.088
Arthropathies and related disorders	0.083
----------------------------------------
Vitamins	0.128
Bone Density Conservation Agents	0.121
Angiotensin-Converting Enzyme Inhibitors	0.110
Antihypertensive Agents	0.102
Antipyretics	0.096
Hypnotics and Sedatives	0.096
Anti-Inflammatory Agents, Non-Steroidal	0.090
Cyclooxygenase Inhibitors	0.089
Fibrinolytic Agents	0.088
Antineoplastic Agents, Hormonal	0.079
===== phenotype 37=================================================================
proportion of pts: 0.109083696946
lambda: 4918.83243177
----------------------------------------
Na	0.173
Hypertensive disease	0.122
Neurotic, personality, nonpsychotic disorders	0.112
Rheumatism, excluding the back	0.102
Drug dependence	0.093
Disorders of lipoid metabolism	0.092
Symptoms involving respiratory system and other chest symptoms	0.083
Dorsopathies	0.078
Arthropathies and related disorders	0.076
General symptoms	0.070
----------------------------------------
Antidepressive Agents, Second-Generation	0.212
Serotonin Uptake Inhibitors	0.206
Antipyretics	0.152
Antihypertensive Agents	0.151
Anti-Inflammatory Agents, Non-Steroidal	0.140
Cyclooxygenase Inhibitors	0.138
===== phenotype 49=================================================================
proportion of pts: 0.100753669179
lambda: 4918.01340952
----------------------------------------
Other forms of heart disease	0.133
Hypertensive disease	0.120
Range name na	0.111
Symptoms involving skin and other integumentary tissue	0.110
General symptoms	0.102
Arthropathies and related disorders	0.096
Symptoms involving respiratory system and other chest symptoms	0.094
Acute respiratory infections	0.080
Anemias	0.078
Diseases of the ear and mastoid process	0.076
----------------------------------------
Anti-Inflammatory Agents	0.193
Diuretics	0.184
Anti-Allergic Agents	0.172
Sodium Potassium Chloride Symporter Inhibitors	0.161
Bronchodilator Agents	0.154
Antihypertensive Agents	0.136
===== phenotype 35=================================================================
proportion of pts: 0.0948036493455
lambda: 4916.34771888
----------------------------------------
Hypertensive disease	0.141
Arthropathies and related disorders	0.115
Diseases of esophagus, stomach, and duodenum	0.114
Rheumatism, excluding the back	0.105
Range name na	0.099
Disorders of lipoid metabolism	0.093
Symptoms involving respiratory system and other chest symptoms	0.089
Other diseases of urinary system	0.086
Symptoms involving digestive system	0.079
Other disorders of female genital tract	0.079
----------------------------------------
Proton Pump Inhibitors	0.160
Anti-Ulcer Agents	0.146
Anti-Allergic Agents	0.146
Anti-Inflammatory Agents	0.140
Bronchodilator Agents	0.140
Antihypertensive Agents	0.097
Adrenergic beta-2 Receptor Agonists	0.091
Estrogens	0.082
===== phenotype 38=================================================================
proportion of pts: 0.10035700119
lambda: 4913.56115742
----------------------------------------
Disorders of the peripheral nervous system	0.147
Diabetes	0.121
Hypertensive disease	0.106
Disorders of lipoid metabolism	0.103
Rheumatism, excluding the back	0.096
Nephritis, nephrotic syndrome, and nephrosis	0.095
Arthropathies and related disorders	0.091
General symptoms	0.086
Anemias	0.079
Range name na	0.076
----------------------------------------
Hypoglycemic Agents	0.216
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.178
Anticholesteremic Agents	0.176
Anticonvulsants	0.154
Analgesics	0.150
Antihypertensive Agents	0.127
===== phenotype 43=================================================================
proportion of pts: 0.0888536295121
lambda: 4902.27590203
----------------------------------------
Disorders of the eye and adnexa	0.156
Acute respiratory infections	0.140
General symptoms	0.126
Range name na	0.123
Hypertensive disease	0.111
Symptoms involving respiratory system and other chest symptoms	0.100
Other symptoms involving abdomen and pelvis	0.085
Infections of skin and subcutaneous tissue	0.082
Other diseases of intestines and peritoneum	0.078
----------------------------------------
Cyclooxygenase Inhibitors	0.111
Anti-Inflammatory Agents, Non-Steroidal	0.109
Anti-Inflammatory Agents	0.105
Antipyretics	0.103
Antihypertensive Agents	0.103
Platelet Aggregation Inhibitors	0.097
Diuretics	0.097
Vasodilator Agents	0.096
Fibrinolytic Agents	0.094
Dermatologic Agents	0.086
===== phenotype 18=================================================================
proportion of pts: 0.0880602935343
lambda: 4305.4470172
----------------------------------------
Hypertensive disease	0.159
Disorders of lipoid metabolism	0.128
Range name na	0.118
Disorders of the eye and adnexa	0.108
Diabetes	0.105
Other diseases of skin and subcutaneous tissue	0.102
Rheumatism, excluding the back	0.102
Disorders of the peripheral nervous system	0.095
General symptoms	0.083
----------------------------------------
Excitatory Amino Acid Antagonists	0.170
Antiparkinson Agents	0.169
Anticonvulsants	0.163
Anti-Anxiety Agents	0.160
Serotonin Uptake Inhibitors	0.134
Analgesics	0.127
Antihypertensive Agents	0.076
===== phenotype 3=================================================================
proportion of pts: 0.0975803252678
lambda: 4128.40498172
----------------------------------------
Other diseases of intestines and peritoneum	0.186
Symptoms involving digestive system	0.148
Hypertensive disease	0.117
Range name na	0.113
Other symptoms involving abdomen and pelvis	0.105
Diseases of esophagus, stomach, and duodenum	0.089
Complications of surgical and medical care, not elsewhere classified	0.084
Other diseases of urinary system	0.083
Certain traumatic complications and unspecified injuries	0.075
----------------------------------------
Analgesics, Opioid	0.164
Narcotics	0.157
Antihypertensive Agents	0.153
Antipyretics	0.135
Hypnotics and Sedatives	0.134
Anti-Anxiety Agents	0.134
Anti-Inflammatory Agents, Non-Steroidal	0.124
===== phenotype 29=================================================================
proportion of pts: 0.0884569615232
lambda: 3917.3493932
----------------------------------------
Symptoms involving digestive system	0.160
Other symptoms involving abdomen and pelvis	0.146
Nonspecific findings on examination of blood	0.100
Liver	0.098
Anemias	0.094
Other diseases of urinary system	0.086
Dorsopathies	0.085
Hypertensive disease	0.080
Disorders of fluid, electrolyte, and acid-base balance	0.080
Symptoms involving skin and other integumentary tissue	0.072
----------------------------------------
Anti-Ulcer Agents	0.156
Antihypertensive Agents	0.150
Anti-Arrhythmia Agents	0.148
Vasodilator Agents	0.146
Cyclooxygenase Inhibitors	0.136
Antipyretics	0.134
Anti-Inflammatory Agents, Non-Steroidal	0.131
===== phenotype 40=================================================================
proportion of pts: 0.0662435541452
lambda: 3658.33095523
----------------------------------------
Miscellaneous diagnostic and therapeutic procedures	0.268
Operations on the cardiovascular system	0.204
Other diseases of respiratory system	0.190
Diseases of veins and lymphatics, and other diseases of circulatory system	0.117
Operations on the musculoskeletal system	0.114
Diseases of arteries, arterioles, and capillaries	0.107
----------------------------------------
Antipyretics	0.136
Antihypertensive Agents	0.135
Anti-Inflammatory Agents, Non-Steroidal	0.130
Cyclooxygenase Inhibitors	0.128
Fibrinolytic Agents	0.123
Platelet Aggregation Inhibitors	0.123
Anti-Arrhythmia Agents	0.116
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.107
===== phenotype 36=================================================================
proportion of pts: 0.0900436334788
lambda: 3539.018473
----------------------------------------
Other disorders of female genital tract	0.135
Range name na	0.124
Dorsopathies	0.121
Hypertensive disease	0.115
Rheumatism, excluding the back	0.100
Arthropathies and related disorders	0.091
Symptoms involving urinary system	0.085
General symptoms	0.083
Disorders of lipoid metabolism	0.074
Pain	0.071
----------------------------------------
Analgesics, Non-Narcotic	0.278
Antihypertensive Agents	0.153
Antipyretics	0.148
Estrogens	0.142
Anti-Inflammatory Agents, Non-Steroidal	0.139
Cyclooxygenase Inhibitors	0.139
===== phenotype 15=================================================================
proportion of pts: 0.0880602935343
lambda: 2949.89593007
----------------------------------------
Dorsopathies	0.129
Range name na	0.111
Rheumatism, excluding the back	0.107
Hypertensive disease	0.104
Symptoms involving urinary system	0.101
Arthropathies and related disorders	0.097
Disorders of lipoid metabolism	0.094
Nonspecific findings on examination of blood	0.092
Organic sleep disorders	0.091
Other diseases of urinary system	0.075
----------------------------------------
Anti-Ulcer Agents	0.255
Anti-Inflammatory Agents	0.250
Bronchodilator Agents	0.248
Anti-Allergic Agents	0.247
===== phenotype 1=================================================================
proportion of pts: 0.0955969853233
lambda: 2859.52512376
----------------------------------------
Hypertensive disease	0.132
Diabetes	0.118
Disorders of lipoid metabolism	0.118
Organic sleep disorders	0.110
Nonspecific findings on examination of blood	0.106
Disorders of the eye and adnexa	0.099
Range name na	0.085
Symptoms involving respiratory system and other chest symptoms	0.078
Diseases of esophagus, stomach, and duodenum	0.077
Arthropathies and related disorders	0.077
----------------------------------------
Calcium Channel Blockers	0.308
Vasodilator Agents	0.264
Analgesics	0.257
Antihypertensive Agents	0.171
===== phenotype 33=================================================================
proportion of pts: 0.0955969853233
lambda: 2762.15764191
----------------------------------------
Hypertensive disease	0.131
Symptoms involving respiratory system and other chest symptoms	0.123
General symptoms	0.121
Other diseases of urinary system	0.101
Pneumonia and influenza	0.093
Other diseases of respiratory system	0.092
Other forms of heart disease	0.089
Acute respiratory infections	0.086
Symptoms involving urinary system	0.084
Other diseases of the upper respiratory tract	0.078
----------------------------------------
Anti-Bacterial Agents	0.345
Anti-Allergic Agents	0.256
Bronchodilator Agents	0.200
Antihypertensive Agents	0.199
===== phenotype 30=================================================================
proportion of pts: 0.0880602935343
lambda: 2713.34016047
----------------------------------------
Hypertensive disease	0.173
Other forms of heart disease	0.163
Symptoms involving respiratory system and other chest symptoms	0.159
Range name na	0.141
Disorders of the eye and adnexa	0.133
Disorders of lipoid metabolism	0.127
General symptoms	0.104
----------------------------------------
Enzyme Inhibitors	0.228
Immunosuppressive Agents	0.212
Dermatologic Agents	0.199
Antimetabolites, Antineoplastic	0.182
Antirheumatic Agents	0.179
===== phenotype 14=================================================================
proportion of pts: 0.0864736215787
lambda: 2526.00247841
----------------------------------------
Hypertensive disease	0.156
Symptoms involving urinary system	0.134
Other diseases of urinary system	0.131
Range name na	0.123
Disorders of lipoid metabolism	0.110
Nephritis, nephrotic syndrome, and nephrosis	0.097
Anemias	0.091
Diseases of esophagus, stomach, and duodenum	0.083
Nonspecific findings on examination of blood	0.077
----------------------------------------
Enzyme Inhibitors	0.240
Dermatologic Agents	0.219
Immunosuppressive Agents	0.200
Antirheumatic Agents	0.176
Antihypertensive Agents	0.165
===== phenotype 6=================================================================
proportion of pts: 0.0761602538675
lambda: 2411.19090565
----------------------------------------
Na	0.128
Hypertensive disease	0.117
Other symptoms involving abdomen and pelvis	0.115
Neurotic, personality, nonpsychotic disorders	0.113
Range name na	0.106
Diseases of esophagus, stomach, and duodenum	0.098
Organic sleep disorders	0.094
Symptoms involving respiratory system and other chest symptoms	0.080
General symptoms	0.077
Other diseases of urinary system	0.071
----------------------------------------
Serotonin Uptake Inhibitors	0.292
Antidepressive Agents, Second-Generation	0.280
Anti-Anxiety Agents	0.228
Antihypertensive Agents	0.201
===== phenotype 4=================================================================
proportion of pts: 0.0805236017453
lambda: 1308.47093397
----------------------------------------
Overweight, obesity and other hyperalimentation	0.143
Symptoms involving skin and other integumentary tissue	0.127
Dorsopathies	0.108
Acute respiratory infections	0.098
Hypertensive disease	0.094
Diabetes	0.093
Anemias	0.088
Symptoms involving respiratory system and other chest symptoms	0.086
Organic sleep disorders	0.083
Disorders of lipoid metabolism	0.080
----------------------------------------
Calcium Channel Blockers	0.585
Antihypertensive Agents	0.415
===== phenotype 26=================================================================
proportion of pts: 0.0606902023007
lambda: 814.986544388
----------------------------------------
Hypertensive disease	0.156
Range name na	0.147
Symptoms involving respiratory system and other chest symptoms	0.120
Disorders of lipoid metabolism	0.109
Other forms of heart disease	0.102
Ischemic heart disease	0.101
Rheumatism, excluding the back	0.097
General symptoms	0.096
Other diseases of respiratory system	0.072
----------------------------------------
Surface-Active Agents	1.000
===== phenotype 10=================================================================
proportion of pts: 0.070606902023
lambda: 670.236126258
----------------------------------------
Symptoms involving respiratory system and other chest symptoms	0.131
Anemias	0.130
Other diseases of respiratory system	0.128
Other forms of heart disease	0.125
Disorders of fluid, electrolyte, and acid-base balance	0.104
Hypertensive disease	0.103
Range name na	0.102
Pain	0.094
Symptoms involving cardiovascular system	0.082
----------------------------------------
Anti-Anxiety Agents	1.000
===== phenotype 41=================================================================
proportion of pts: 0.0
lambda: 1.0
----------------------------------------
----------------------------------------
===== phenotype 23=================================================================
proportion of pts: 0.0
lambda: 1.0
----------------------------------------
----------------------------------------
